Anteris Technologies Aims for a Significant Slice of the US Transcatheter Valve Market by 2030
Anteris Technologies targets a 4%-5% share of the US transcatheter valve replacement market by 2030, sparking interest in medical technology investments.
Articles for tag: Abbott Laboratories, Anteris Technologies, healthcare innovation, heart valve, investment analysis, market share, medical technology, transcatheter valve replacement, US market
